Séance 8. SÉANCE COMMUNE AVEC LE COLLÈGE ITALIEN DE PHLÉBOLOGIE

Résumé

Aim of this clinical, instrumental, observational research is to observe the anticoagulant effect of rivaroxaban
in patients with recent and previous DVT. We examined with clinical approach and duplex 6 patients affected by
DVT. 4 patients with previous politeo-femoral DVT and VTE mean age 50-70, males with Femoral total recanalization and 30% of popliteal recanalization. These patients were in therapy with inhibitors K vitamin since 4 years
but they had no compliance with this therapy for kind of life (frequent long distance travel and diet observance)
For this reason we passed to new anticoagulant therapy, (rivaroxaban). 2 patients, one male, one female mean age
70-85 years, with recent femoral DVT and previous (about 3 years ago) popliteal-femoral DVT with femoral vein
recanalization. These 2 patients were intolerant to Heparins and for that and to avoid the blood controls, preferred
the new anticoagulants therapy.